Changeflow GovPing Banking & Finance Early Stage Funding Considerations — SAFEs and ...
Routine Notice Added Final

Early Stage Funding Considerations — SAFEs and Convertible Notes

Favicon for www.jdsupra.com JD Supra Finance & Banking
Published
Detected
Email

Summary

Lowenstein Sandler LLP published a podcast transcript explaining SAFEs (Simple Agreements for Future Equity) and convertible notes as early-stage funding instruments. The discussion covers the basics and nuances of these equity financing tools for startup founders and investors, including their similarities, differences, and implications for both parties. This is an informational resource from a law firm without any regulatory mandates or compliance obligations.

Published by Lowenstein Sandler on jdsupra.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document presents an educational discussion of SAFE agreements and convertible notes as early-stage financing mechanisms. It explains how SAFEs convert to equity upon future priced rounds without creating debt obligations, and how convertible notes function as short-term debt that converts to equity, potentially with interest accrual. For founders, the choice affects dilution, timing of valuation setting, and financing complexity. For investors, differences in risk profile, conversion mechanics, and rights attached to resulting equity are relevant considerations. No regulatory changes or compliance obligations are created by this document.

Archived snapshot

Apr 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

April 16, 2026

Early Stage Funding Considerations — SAFEs and Convertible Notes

Laura Cicirelli, Eric Weiner Lowenstein Sandler LLP + Follow Contact LinkedIn Facebook X ;) Embed

In this episode of The Founder's Hour, hosts Laura Cicirelli and Eric Weiner discuss SAFEs and convertible notes as early stage funding options, explaining the similarities and differences between the two. They cover both the basics and the nuances of these instruments, as well as their impacts on the founders that sell them and the investors that buy them.

Speakers:

Laura Cicirelli, Partner, Emerging Companies & Venture Capital

Eric Weiner, Partner, Emerging Companies & Venture Capital

;) ;) Report

Latest Posts

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
Attorney Advertising.

©
Lowenstein Sandler LLP

Written by:

Lowenstein Sandler LLP Contact + Follow Laura Cicirelli + Follow Eric Weiner + Follow more less

PUBLISH YOUR CONTENT ON JD SUPRA

  • ✔ Increased readership
  • ✔ Actionable analytics
  • ✔ Ongoing writing guidance Join more than 70,000 authors publishing their insights on JD Supra

Start Publishing »

Published In:

Capital Markets + Follow Capital Raising + Follow Convertible Notes + Follow Corporate Finance + Follow Early Stage Companies + Follow Emerging Growth Companies + Follow Entrepreneurs + Follow Equity + Follow Equity Financing + Follow Investors + Follow Seed Financing + Follow Venture Capital + Follow General Business + Follow Finance & Banking + Follow Securities + Follow more less

Lowenstein Sandler LLP on:

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign Up Log in ** By using the service, you signify your acceptance of JD Supra's Privacy Policy.* - hide - hide

Get daily alerts for JD Supra Finance & Banking

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from Lowenstein Sandler.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
Lowenstein Sandler
Published
April 16th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Entrepreneurs Investors
Industry sector
5231 Securities & Investments
Activity scope
Early-stage funding Equity financing Venture capital
Geographic scope
United States US

Taxonomy

Primary area
Securities
Operational domain
Legal
Topics
Capital Markets Corporate Finance

Get alerts for this source

We'll email you when JD Supra Finance & Banking publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!